intravenous albuterol has also been employed in acutely dyspneic patients , but produces more side effects than carefully administered intravenous theophylline , is impaired by lack of sufficient pharmacokinetic information to guide dosing , and is of uncertain efficacy in the asthmatic with respiratory failure .
C0001927
albuterol
C0004096
asthmatic